23/04/2019 20:00:00

Class Action Alert CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC

NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Conagra Brands, Inc. (NYSE:

CAG

)

Class Period: June 27, 2018 - December 19, 2018, and/or purchased shares of Conagra’s common stock pursuant and/or traceable to Conagra’s secondary public offering commenced on or about October 9, 2018 (“SPO”)

Deadline: April 23, 2019

For more info:www.bgandg.com/cag

The Complaint alleges that Defendants made materially false and misleading statements and/or failed to disclose that material information about Conagra’s acquisition of Pinnacle Foods, Inc. (“Pinnacle”), including that: (1) Conagra inadequately performed proper due diligence in connection with the acquisition of Pinnacle; (2) the performance of Pinnacle’s three leading brands was not deteriorating due to intensified competition, but to self-inflicted subpar innovation and executional missteps; (3) Pinnacle’s business was performing so poorly that it had resorted to pushing promotional deals to retailers in an effort to boost sales; and (4) consequently, Defendant’s public statements were materially false and/or misleading and/or lacked a reasonable basis when made.

Diplomat Pharmacy, Inc. (NYSE: DPLO)

Class Period: February 26, 2018 - February 21, 2019,

Deadline: April 25, 2019

For more info:www.bgandg.com/dplo

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) Diplomat had downplayed its success in integrating and growing its PBM business, which included LDI Integrated and National Pharmaceutical, two companies Diplomat had acquired in late 2017; (2) consequently, Diplomat would need to record a non-cash impairment charge upwards of approximately $630 million relating to its PBM business and these 2017 acquisitions; (3) due to the foregoing, Diplomat would withdraw its preliminary 2019 full-year outlook issued less than seven weeks prior; and (4) as a result, defendants’ statements about Diplomat’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO)

Class Period: August 4, 2016 - January 31, 2019

Deadline: April 26, 2019

For more info:www.bgandg.com/aveo

The Complaint alleges that Defendants made materially false and misleading statements and/or failed to disclose that: (1) the TIVO‑3 trial was inadequately designed to address the OS concerns regarding AVEO’s lead candidate drug, tivozanib, from the TIVO-1 trial presented in the June 2013; (2) tivozanib had insufficient survival data to meet FDA approval following its initial 2013 rejection; (3) this lack of sufficient survival data would put tivozanib at greater risk of delayed FDA approval; and (4) as a result, AVEO’s public statements were materially false and misleading at all relevant times.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz

212-697-6484 | info@bgandg.com

BGG Logo.jpg

Related content
30 Apr - 
NYSE: DPLO Investor Notice: Lawsuit against Diplomat Ph..
29 Apr - 
NYSE: CAG Investor Notice: Lawsuit against Conagra Bran..
26 Apr - 
APRIL 25 DEADLINE: Bragar Eagel & Squire, P.C. Announce..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
MODERN HEALTHCARE RECOGNIZES NEVADA LEADER AS ONE OF THE NATION’S 50 MOST INFLUENTIAL U.S. CLINICAL EXECUTIVES
2
Establishment Labs Announces Additional Financing and Improved Terms with Amendment to Existing Credit Agreement
3
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Zuora, Inc.
4
LEAD PLAINTIFF DEADLINES for INVVY, JMIA, MOMO and AAC:  Hagens Berman Reminds INVVY, JMIA, MOMO and AAC Investors of Upcoming Lead Plaintiff Deadlines
5
Nevada Copper Announces AGM Results; Remains on Schedule to Enter Production Q4, 2019

Related stock quotes

ConAgra Brands Inc 29.12 -0.7% Stock price decreasing
Aveo Pharmaceuticals Inc 0.7156 -1.1% Stock price decreasing
Diplomat Pharmacy Inc 4.510 4.6% Stock price increasing

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
18 June 2019 20:33:25
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB4 - 2019-06-18 21:33:25 - 2019-06-18 20:33:25 - 1000 - Website: OKAY